Seroatlas · Human Serome Atlas

ZCCHC2

Zinc finger CCHC domain-containing protein 2

Also known as: C18orf49, FLJ20222, FLJ20281, KIAA1744, ZCHC2_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9C0B9
Gene
ZCCHC2
Ensembl
ENSG00000141664
Chromosome
18
Canonical length
1178 aa
Protein class
Predicted intracellular proteins
Subcellular location
Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol

OverviewNCBI Gene

Predicted to enable nucleic acid binding activity; phosphatidylinositol binding activity; and zinc ion binding activity. Located in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]

Canonical amino-acid sequenceUniProt

1178 residues, UniProt reviewed canonical sequence.

>Q9C0B9|ZCCHC2
     1  MLRMKLPLKP THPAEPPPEA EEPEADARPG AKAPSRRRRD CRPPPPPPPP AGPSRGPLPP
    61  PPPPRGLGPP VAGGAAAGAG MPGGGGGPSA ALREQERVYE WFGLVLGSAQ RLEFMCGLLD
   121  LCNPLELRFL GSCLEDLARK DYHYLRDSEA KANGLSDPGP LADFREPAVR SRLIVYLALL
   181  GSENREAAGR LHRLLPQVDS VLKSLRAARG EGSRGGAEDE RGEDGDGEQD AEKDGSGPEG
   241  GIVEPRVGGG LGSRAQEELL LLFTMASLHP AFSFHQRVTL REHLERLRAA LRGGPEDAEV
   301  EVEPCKFAGP RAQNNSAHGD YMQNNESSLI EQAPIPQDGL TVAPHRAQRE AVHIEKIMLK
   361  GVQRKRADKY WEYTFKVNWS DLSVTTVTKT HQELQEFLLK LPKELSSETF DKTILRALNQ
   421  GSLKREERRH PDLEPILRQL FSSSSQAFLQ SQKVHSFFQS ISSDSLHSIN NLQSSLKTSK
   481  ILEHLKEDSS EASSQEEDVL QHAIIHKKHT GKSPIVNNIG TSCSPLDGLT MQYSEQNGIV
   541  DWRKQSCTTI QHPEHCVTSA DQHSAEKRSL SSINKKKGKP QTEKEKIKKT DNRLNSRING
   601  IRLSTPQHAH GGTVKDVNLD IGSGHDTCGE TSSESYSSPS SPRHDGRESF ESEEEKDRDT
   661  DSNSEDSGNP STTRFTGYGS VNQTVTVKPP VQIASLGNEN GNLLEDPLNS PKYQHISFMP
   721  TLHCVMHNGA QKSEVVVPAP KPADGKTIGM LVPSPVAISA IRESANSTPV GILGPTACTG
   781  ESEKHLELLA SPLPIPSTFL PHSSTPALHL TVQRLKLPPP QGSSESCTVN IPQQPPGSLS
   841  IASPNTAFIP IHNPGSFPGS PVATTDPITK SASQVVGLNQ MVPQIEGNTG TVPQPTNVKV
   901  VLPAAGLSAA QPPASYPLPG SPLAAGVLPS QNSSVLSTAA TSPQPASAGI SQAQATVPPA
   961  VPTHTPGPAP SPSPALTHST AQSDSTSYIS AVGNTNANGT VVPPQQMGSG PCGSCGRRCS
  1021  CGTNGNLQLN SYYYPNPMPG PMYRVPSFFT LPSICNGSYL NQAHQSNGNQ LPFFLPQTPY
  1081  ANGLVHDPVM GSQANYGMQQ MAGFGRFYPV YPAPNVVANT SGSGPKKNGN VSCYNCGVSG
  1141  HYAQDCKQSS MEANQQGTYR LRYAPPLPPS NDTLDSAD

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against ZCCHC2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.63
Highest tissue expression
35 nTPM

Expression across tissuesHPA

Tissue

  • salivary gland: 35 nTPM
  • bone marrow: 25 nTPM
  • liver: 22 nTPM
  • blood vessel: 14 nTPM
  • skeletal muscle: 12 nTPM
  • testis: 11 nTPM

Single-cell type

  • salivary acinar cells: 252 nCPM
  • late spermatids: 223 nCPM
  • innate lymphoid cells: 198 nCPM
  • lactotrophs: 163 nCPM
  • early spermatids: 152 nCPM
  • somatotrophs: 150 nCPM

Immune cell

  • neutrophil: 1.5 nTPM
  • eosinophil: 0.8 nTPM
  • naive CD4 T-cell: 0.6 nTPM
  • gdT-cell: 0.5 nTPM
  • intermediate monocyte: 0.5 nTPM
  • MAIT T-cell: 0.4 nTPM

Brain region

  • white matter: 36 nTPM
  • cerebellum: 32 nTPM
  • cerebral cortex: 30 nTPM
  • medulla oblongata: 29 nTPM
  • midbrain: 28 nTPM
  • hypothalamus: 28 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.28
gnomAD pLI
0.99
gnomAD missense Z
0.45
DepMap mean gene effect
0.02
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads ZCCHC2 as an antibody target. Whether an autoantibody or antibody against ZCCHC2 could matter depends on whether native ZCCHC2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

ZCCHC2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label ZCCHC2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/ZCCHC2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...